BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 34034222)

  • 21. Generation and characterization of the human iPSC line CABi001-A from a patient with retinitis pigmentosa caused by a novel mutation in PRPF31 gene.
    de la Cerda B; Díez-Lloret A; Ponte B; Vallés-Saiz L; Calado SM; Rodríguez-Bocanegra E; Garcia-Delgado AB; Moya-Molina M; Bhattacharya SS; Díaz-Corrales FJ
    Stem Cell Res; 2019 Apr; 36():101426. PubMed ID: 30921587
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Generation of a human iPS cell line from a patient with retinitis pigmentosa due to EYS mutation.
    Calado SM; Garcia-Delgado AB; De la Cerda B; Ponte-Zuñiga B; Bhattacharya SS; Díaz-Corrales FJ
    Stem Cell Res; 2018 Dec; 33():251-254. PubMed ID: 30471616
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Generation of two human iPSC lines (HIMRi002-A and HIMRi003-A) derived from Caveolinopathy patients with rippling muscle disease.
    Boeing A; Mavrommatis L; Daya NM; Zhuge H; Volke L; Kocabas A; Kneifel M; Athamneh M; Krause K; Südkamp N; Döring K; Theiss C; Roos A; Zaehres H; Güttsches AK; Vorgerd M
    Stem Cell Res; 2023 Oct; 72():103220. PubMed ID: 37839261
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Generation of two Alpha-I antitrypsin deficiency patient-derived induced pluripotent stem cell lines ISRM-AATD-iPSC-1 (HHUUKDi011-A) and ISRM-AATD-iPSC-2 (HHUUKDi012-A).
    Ncube A; Bewersdorf L; Spitzhorn LS; Loerch C; Bohndorf M; Graffmann N; May L; Amzou S; Fromme M; Wruck W; Strnad P; Adjaye J
    Stem Cell Res; 2023 Sep; 71():103171. PubMed ID: 37506509
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Generation of a human iPSC line (HIMRi001-A) from a patient with filaminopathy.
    Daya NM; Mavrommatis L; Zhuge H; Athamneh M; Roos A; Gläser D; Doering K; Zaehres H; Vorgerd M; Güttsches AK
    Stem Cell Res; 2023 Oct; 72():103210. PubMed ID: 37748332
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of mutations in the AIPL1, CRB1, GUCY2D, RPE65, and RPGRIP1 genes in patients with juvenile retinitis pigmentosa.
    Booij JC; Florijn RJ; ten Brink JB; Loves W; Meire F; van Schooneveld MJ; de Jong PT; Bergen AA
    J Med Genet; 2005 Nov; 42(11):e67. PubMed ID: 16272259
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Generation of an induced pluripotent stem cell (iPSC) line from a patient with autosomal dominant retinitis pigmentosa due to a mutation in the NR2E3 gene.
    Terray A; Slembrouck A; Nanteau C; Chondroyer C; Zeitz C; Sahel JA; Audo I; Reichman S; Goureau O
    Stem Cell Res; 2017 Oct; 24():1-4. PubMed ID: 29034877
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Generation of a human iPSC line from a patient with retinitis pigmentosa caused by mutation in PRPF8 gene.
    Lukovic D; Bolinches-Amorós A; Artero-Castro A; Pascual B; Carballo M; Hernan I; Erceg S
    Stem Cell Res; 2017 May; 21():23-25. PubMed ID: 28677533
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of CRB1 splicing in retinal organoids derived from a patient with adult-onset rod-cone dystrophy caused by the c.1892A>G and c.2548G>A variants.
    Zhang X; Thompson JA; Zhang D; Charng J; Arunachalam S; McLaren TL; Lamey TM; De Roach JN; Jennings L; McLenachan S; Chen FK
    Mol Genet Genomic Med; 2020 Nov; 8(11):e1489. PubMed ID: 32931148
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Generation of induced pluripotent stem cell line NIMHi010-A from dermal fibroblast cells of a healthy individual.
    Dash SS; Arunachal G; Nimonkar MM; Vengalil S; Nashi S; Chetan GK; Boddu VK; Nalini A; Markandeya YS
    Stem Cell Res; 2024 Apr; 76():103355. PubMed ID: 38412659
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Establishment of an induced pluripotent stem (iPS) cell line from dermal fibroblasts of an asymptomatic patient with dominant PRPF31 mutation.
    Terray A; Fort V; Slembrouck A; Nanteau C; Sahel JA; Reichman S; Audo I; Goureau O
    Stem Cell Res; 2017 Dec; 25():26-29. PubMed ID: 29040912
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Generation of two induced pluripotent stem cells lines from Mucopolysaccharydosis IIIA patient: IMEDEAi004-A and IMEDEAi004-B.
    Vallejo S; Fleischer A; Martín JM; Sánchez A; Palomino E; Bachiller D
    Stem Cell Res; 2018 Oct; 32():110-114. PubMed ID: 30269021
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Generation and characterization of iPS cell line (CTGUi001-A) from skin fibroblasts of a patient with Fabry disease.
    Qin Y; Zhan JQ; Ma CJ; Cao CY; Zhang Y; Min YT; Lv YF
    Stem Cell Res; 2023 Jun; 69():103063. PubMed ID: 36917862
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Generation of induced pluripotent stem cell (iPSC) line from Charcot-Marie-Tooth disease patient with MPZ mutation (CMT1B).
    Son D; Kang PJ; Yun W; You S
    Stem Cell Res; 2017 Oct; 24():5-7. PubMed ID: 29034895
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Generation of an induced pluripotent stem cell line from a patient with non-syndromic CLN3-associated retinal degeneration and a coisogenic control line.
    Zhang X; Zhang D; Chen SC; Lamey T; Thompson JA; McLaren T; De Roach JN; Chen FK; McLenachan S
    Stem Cell Res; 2018 May; 29():245-249. PubMed ID: 29753273
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Generation of the induced pluripotent stem cell line from a patient with autosomal recessive ABCA4-mediated Stargardt Macular Dystrophy.
    Claassen JN; Zhang D; Chen SC; Moon SY; Lamey T; Thompson JA; McLaren T; De Roach JN; McLenachan S; Chen FK
    Stem Cell Res; 2019 Jan; 34():101352. PubMed ID: 30634128
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Generation of induced pluripotent stem cell line (ZZUi0016-A) from dermal fibroblasts of a normal human.
    Gao Y; Wang Y; Wang Z; Sun H; Zhang R; Yang J; Liu Y; Liu H; Zhang Q; Zhang S; Shi C; Xu Y; Song B
    Stem Cell Res; 2020 Mar; 43():101717. PubMed ID: 32007761
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A case of CRB1-negative Coats-like retinitis pigmentosa.
    Sarao V; Veritti D; Prosperi R; Pignatto S; Lanzetta P
    J AAPOS; 2013 Aug; 17(4):414-6. PubMed ID: 23871396
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Establishment of induced pluripotent stem cell line CSUASOi004-A by reprogramming peripheral blood mononuclear cells of a PRPF6-related dominant retinitis pigmentosa patient.
    Zhou Y; Jing Y; Mao S; Liu J; Cui Z; Wang Y; Chen J; Chan HF; Tang S; Chen J
    Stem Cell Res; 2020 May; 45():101793. PubMed ID: 32335390
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Generation of an induced pluripotent stem cell line (SDASi001-A) from a Schimke immune-osseous dysplasia patient with SMARCAL1 mutations.
    Wang X; Zhang H; Wang X; Zhou W; Dong L; Li N; He Q
    Stem Cell Res; 2023 Oct; 72():103217. PubMed ID: 37788557
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.